Endogenous cannabinoids induce fever through the activation of CB1 receptors

British Journal of Pharmacology

Volumn 157, Issue 8, 2009, Pages 1494-1501

  Fraga, D ^a   Zanoni, C I S ^a   Rae, G A ^b   Parada, C A ^c   Souza, G E P ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

^c UNIVERSITY OF CAMPINAS   (Brazil)

Author keywords

ACEA; AM1241; AM251; AM630; Anandamide; Capsazepine; Fever; LPS; URB597

Indexed keywords

1 (2,4 DICHLOROPHENYL) 5 (4 IODOPHENYL) 4 METHYL N (1 PIPERIDYL) 1H PYRAZOLE 3 CARBOXAMIDE; 3 (2 IODO 5 NITROBENZOYL) 1 (1 METHYL 2 PIPERIDINYLMETHYL)INDOLE; 6 IODO 3 (4 METHOXYBENZOYL) 2 METHYL 1 (2 MORPHOLINOETHYL)INDOLE; ANANDAMIDE; ARACHIDONYL 2 CHLOROETHYLAMIDE; CANNABINOID 1 RECEPTOR; CANNABINOID 1 RECEPTOR AGONIST; CAPSAZEPINE; CYCLOHEXYLCARBAMIC ACID 3' CARBAMOYLBIPHENYL 3 YL ESTER; ENDOCANNABINOID; LIPOPOLYSACCHARIDE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIPYRETIC ACTIVITY; ARTICLE; CONTROLLED STUDY; CORE TEMPERATURE; DOSE RESPONSE; DRUG DOSE COMPARISON; FEVER; HEAT LOSS; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RECTUM; SKIN TEMPERATURE; TAIL; THERMISTOR; THERMOREGULATION;

ANIMALS; ARACHIDONIC ACIDS; BODY TEMPERATURE; BODY TEMPERATURE REGULATION; CANNABINOIDS; ENDOCANNABINOIDS; FEVER; LIPOPOLYSACCHARIDES; MALE; PIPERIDINES; POLYUNSATURATED ALKAMIDES; PYRAZOLES; RATS; RATS, WISTAR; RECEPTOR, CANNABINOID, CB1; RECEPTOR, CANNABINOID, CB2;

EID: 70350346857     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00312.x     Document Type: Article

References (46)

1. Beltramo M, Stella N, Calignano A, Lin SY, Makriyannis A, Piomelli D (1997). Functional role of high-affinity anandamide transport, as revealed by selective inhibition. Science 277: 1094-1097.
2. Benamar K, Yondorf M, Meissler JJ, Geller EB, Tallarida RJ, Eisenstein TK et al. (2007). A novel role of cannabinoids: implication in the fever induced by bacterial lipopolysaccharide. J Pharmacol Exp Ther 320: 1127-1133.
3. Boulant JA (2000). Role of the preoptic-anterior hypothalamus in thermoregulation and fever. Clin Infect Dis 31 (Suppl. 5): S157-S161.
4. Chaperon F, Thiebot MH (1999). Behavioral effects of cannabinoid agents in animals. Crit Rev Neurobiol 13: 243-281.
5. Costa B, Vailati S, Colleoni M (1999). SR 141716A, a cannabi-noid receptor antagonist, reverses the behavioural effects of anandamide-treated rats. Behav Pharmacol 10: 327-331.
6. Cravatt BF, Giang DK, Mayfield SP, Boger DL, Lerner RA, Gilula NB (1996). Molecular characterization of an enzyme that degrades neu-romodulatory fatty-acid amides. Nature 384: 83-87.
7. Crawley JN, Corwin RL, Robinson JK, Felder CC, Devane WA, Axelrod J (1993). Anandamide, an endogenous ligand of the cannabinoid receptor, induces hypomotility and hypothermia in vivo in rodents. Pharmacol Biochem Behav 46: 967-972.
8. Devane WA, Hanus L, Breuer A, Pertwee RG, Stevenson LA, Griffin G et al. (1992). Isolation and structure of a brain constituent that binds to the cannabinoid receptor. Science 258: 1946-1949.
9. Dinarello CA (1984). Interleukin-1. Rev Infect Dis 6: 51-95.
10. Dinarello CA, Cannon JG, Mancilla J, Bishai I, Lees J, Coceani F (1991). Interleukin-6 as an endogenous pyrogen: induction of pros-taglandin E2 in brain but not in peripheral blood mononuclear cells. Brain Res 562: 199-206.
11. Dinarello CA, Cannon JG, Wolff SM, Bernheim HA, Beutler B, Cerami A et al. (1986). Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. J Exp Med 163: 1433-1450.
12. Fabricio AS, Silva CA, Rae GA, D'Orleans-Juste P, Souza GE (1998). Essential role for endothelin ET(B) receptors in fever induced by LPS (E. coli) in rats. Br J Pharmacol 125: 542-548.
13. Fennessy MR, Taylor DA (1977). The effect of delta9-tetrahydrocannabinol on body temperature and brain amine concentrations in the rat at different ambient temperatures. Br J Pharmacol 60: 65-71.
14. Fitton AG, Pertwee RG (1982). Changes in body temperature and oxygen consumption rate of conscious mice produced by intrahypothalamic and intracerebroventricular injection of D9-tetrahydrocannabinol (D9-THC). Br J Pharmacol 75: 409-414.
15. Fraga D, Machado RR, Fernandes LC, Souza GE, Zampronio AR (2008). Endogenous opioids: role in prostaglandin-dependent and-independent fever. Am J Physiol Regul Integr Comp Physiol 294: R411-R420.
16. Goparaju SK, Kurahashi Y, Suzuki H, Ueda N, Yamamoto S (1999a). Anandamide amidohydrolase of porcine brain: cDNA cloning, functional expression and site-directed mutagenesis(1). Biochim Biophys Acta 1441: 77-84.
17. Goparaju SK, Ueda N, Taniguchi K, Yamamoto S (1999b). Enzymes of porcine brain hydrolyzing 2-arachidonoylglycerol, an endogenous ligand of cannabinoid receptors. Biochem Pharmacol 57: 417-423. (Pubitemid 29065290)
18. Gordon CJ (1990). Thermal biology of the laboratory rat. Physiol Behav 47: 963-991.
19. Helle M, Brakenhoff JP, De Groot ER, Aarden LA (1988). Interleukin 6 is involved in interleukin 1-induced activities. Eur J Immunol 18: 957-959.
20. Hillard CJ, Campbell WB (1997). Biochem and pharmacology of arachidonylethanolamide, a putative endogenous cannabinoid. J Lipid Res 38: 2383-2398.
21. Hillard CJ, Edgemond WS, Jarrahian A, Campbell WB (1997). Accumulation of N-arachidonoylethanolamine (anandamide) into cerebellar granule cells occurs via facilitated diffusion. J Neurochem 69: 631-638.
22. Holtzman D, Lovell RA, Jaffe JH, Freedman DX (1969). 1-delta9- tetrahydrocannabinol: neurochemical and behavioral effects in the mouse. Science 163: 1464-1467.
23. Howlett AC (2002). The cannabinoid receptors. Prostaglandins Other Lipid Mediat 68-69: 619-631.
24. Lomax P, Campbell C (1971). Phenitrone and marihuana induced hypothermia. Experientia 27: 1191-1192.
25. Mackie K (2008). Cannabinoid receptors: where they are and what they do. J Neuroendocrinol 20 (Suppl. 1): 10-14.
26. Matsuda LA, Lolait SJ, Brownstein MJ, Young AC, Bonner TI (1990). Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 346: 561-564.
27. Mechoulam R, Gaoni Y (1965a). Hashish. IV. The isolation and structure of cannabinolic cannabidiolic and cannabigerolic acids. Tetrahedron 21: 1223-1229.
28. Mechoulam R, Gaoni Y (1965b). A total synthesis of dl-delta-1- tetrahydrocannabinol, the active constituent of hashish. J Am Chem Soc 87: 3273-3275.
29. Mechoulam R, Ben-Shabat S, Hanus L, Ligumsky M, Kaminski NE, Schatz AR et al. (1995). Identification of an endogenous 2-monoglyceride, present in canine gut, that binds to cannabinoid receptors. Biochem Pharmacol 50: 83-90.
30. Moldrich G, Wenger T (2000). Localization of the CB1 cannabinoid receptor in the rat brain. An immunohistochemical study. Peptides 21: 1735-1742.
31. Munro S, Thomas KL, Abu-Shaar M (1993). Molecular characterization of a peripheral receptor for cannabinoids. Nature 365: 61-65.
32. Ovadia H, Wohlman A, Mechoulam R, Weidenfeld J (1995). Characterization of the hypothermic effect of the synthetic canabinnoid HU-210 in the rat. Relation to the adrenergic system and endogenous pyrogens. Neuropharmacology 34: 175-180.
33. Paxinos G, Watson C, Pennisi M, Topple A (1985). Bregma, lambda and the interaural midpoint in stereotaxic surgery with rats of different sex, strain and weight. J Neurosci Methods 13: 139-143.
34. Pertwee RG (1997). Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol Ther 74: 129-180.
35. Pertwee RG (2005). Pharmacological actions of cannabinoids. Handb Exp Pharmacol 168: 1-51.
36. Pertwee RG (2008). Ligands that target cannabinoid receptors in the brain: from THC to anandamide and beyond. Addict Biol 13: 147-159.
37. Rawls SM, Cabassa J, Geller EB, Adler MW (2002). CB1 receptors in the preoptic anterior hypothalamus regulate WIN 55212-2 [(4, 5-dihydro-2-methyl-4(4- morpholinylmethyl)-1-(1-naphthalenyl-carbonyl)-6H-pyrrolo[3,2,1ij] quinolin-6-one]-induced hypothermia. J Pharmacol Exp Ther 301: 963-968.
38. Rice AS, Farquhar-Smith WP, Nagy I (2002). Endocannabinoids and pain: spinal and peripheral analgesia in inflammation and neuropathy. Prostaglandins Leukot Essent Fatty Acids 66: 243-256.
39. Romanovsky AA, Ivanov AI, Shimansky YP (2002). Selected contribution: ambient temperature for experiments in rats: a new method for determining the zone of thermal neutrality. J Appl Physiol 92: 2667-2679.
40. Roth J, Souza GEP (2001). Fever induction pathways: evidence from responses to systemic or local cytokine formation. Braz J Med Biol Res 34: 301-314.
41. Rothwell NJ (1990). Central activation of thermogenesis by prostag-landins: dependence on CRF. Horm Metab Res 22: 616-618.
42. Sofia RD (1972). A paradoxical effect for 1-tetrahydrocannabinol on rectal temperature in rats. Res Commun Chem Pathol Pharmacol 4: 281-288.
43. Taylor DA, Fennessy MR (1977). Biphasic nature of the effects of D9-tetrahydrocannabinol on body temperature and brain amines of the rat. Eur J Pharmacol 46: 93-99.
44. Tsou K, Brown S, Sanudo-Pena MC, Mackie K, Walker JM (1998). Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 83: 393-411.
45. Valenzano KJ, Sun Q (2004). Current perspectives on the therapeutic utility of VR1 antagonists. Curr Med Chem 11: 3185-3202.
46. Zeisberger E (1999). From humoral fever to neuroimmunological control of fever. J Therm Biol 24: 287-326.